Resilience and Lilly invest $750M to boost Cincinnati drug production

Resilience and Lilly invest $750M to boost Cincinnati drug production is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nathan Owens · 2026-07-31

The expansion will create 400 jobs dedicated to making GLP-1 injectables across Resilience’s contract manufacturing facilities.

Source: BioPharma Dive